Holen Sie sich die Stockscreener-App
78.42
1.25%
-0.97
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$79.39
Offen:
$80.4
24-Stunden-Volumen:
721.69K
Relative Volume:
0.42
Marktkapitalisierung:
$38.50B
Einnahmen:
$10.19B
Nettoeinkommen (Verlust:
$1.05B
KGV:
37.26
EPS:
2.1044
Netto-Cashflow:
$1.38B
1W Leistung:
+0.03%
1M Leistung:
-3.05%
6M Leistung:
-8.88%
1J Leistung:
-11.08%
1-Tages-Spanne:
$78.15
$80.77
1-Wochen-Bereich:
$77.44
$81.05
52-Wochen-Spanne:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
78.38 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
476.37 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
177.87 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
45.06 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
247.00 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Herabstufung | Stifel | Buy → Hold |
| 2025-12-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
RBC Capital Sticks to Its Buy Rating for Alcon (ALC) - The Globe and Mail
RBC Expects Alcon's Upcoming FY26 Guidance to Drive Share Price Volatility; Outperform Rating Kept - marketscreener.com
Alcon Inc. (ALC) Stock Analysis: A Prescription For 16.45% Potential Upside - DirectorsTalk Interviews
Alcon | 2/5/26 - ktnv.com
STAAR Surgical Company (STAA): A Bull Case Theory - Finviz
Tesla, Musk likely can't escape 'Blade Runner 2049' lawsuit, judge says - Reuters
Alcon’s Precision7 Weekly Lenses Test Comfort Claims And Growth Hopes - Yahoo Finance
STAAR Surgical sinks as it plans to terminate sale to Alcon (update) - MSN
STAAR names interim co-CEOs amid search for permanent leader - MedTech Dive
Alcon Inc. (ALC): A Bull Case Theory - Finviz
Alcon Inc. (ALC): A bull case theory - MSN
Alcon launches one-week replacement contact lens in Canada By Investing.com - Investing.com Nigeria
Aug Reactions: Should I hold or sell Alcon Inc nowCPI Data & Weekly Setup with ROI Potential - baoquankhu1.vn
See clearly with Alcon Contacts - WSBT
Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Rep - GuruFocus
Alcon launches one-week replacement contact lens in Canada - Investing.com
Alcon lance PRECISION7 au Canada, des lentilles cornéennes révolutionnaires à remplacement hebdomadaire pour commencer chaque semaine avec une nouvelle paire de lentillesMC - Eagle-Tribune
Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week Fresh - GazetteXtra
VIX Spike: Should I invest in Alcon Inc before earningsWeekly Investment Recap & Consistent Growth Stock Picks - baoquankhu1.vn
Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems - Benzinga
William Blair initiates coverage on Alcon stock with Market Perform rating - Investing.com Nigeria
Dry Eye Disease Market Is Booming Worldwide 2026-2033 | Novartis - openPR.com
Ideas Watch: Will Alcon Inc stock go up in YEAR2025 Market Overview & Daily Volume Surge Signals - baoquankhu1.vn
Buyout Rumor: Does Alcon Inc stock benefit from AI growthTrade Entry Report & High Win Rate Trade Alerts - baoquankhu1.vn
Alcon - WCIV
Will Alcon Inc. stock go up in YEARJuly 2025 Volume & AI Enhanced Trading Alerts - mfd.ru
GPT Infraprojects Approved Acquisition Of 100% Stake In Alcon Builders And Engineers For 1.54 Billion Rupees - TradingView
Retail Trends: Will Alcon Inc stock go up in YEARQuarterly Risk Review & Low Risk Entry Point Guides - baoquankhu1.vn
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
Myopia And Presbyopia Treatment Market Is Going to Boom | ALCON - openPR.com
Berenberg Keeps Alcon at Buy on Expected FY26 Product-supported Growth - marketscreener.com
Is Alcon Inc.'s (VTX:ALC) Recent Stock Performance Influenced By Its Financials In Any Way? - Yahoo Finance
Aug Action: Is Alcon Inc benefiting from innovation trendsJuly 2025 Movers & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Institution Moves: Is Atmos Energy Corporation currently under institutional pressureJuly 2025 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn
Broadwood pushes for removal of 3 STAAR Surgical board members - MSN
ALC.SW Alcon Inc. (SIX) pre-market: CHF64.68, most active ahead of Feb earnings - Meyka
Alcon completes $750 million share repurchase program By Investing.com - Investing.com Australia
Alcon Completes $750 Million Share Repurchase Program - TradingView
ALC.SW Alcon Inc. (SIX) 20 Jan 2026: CHF62.54 close, high volume highlights outlook - Meyka
Alcon completes $750 million share repurchase program - Investing.com
Deutsche Bank Upgrades Alcon to Buy Rating, Boosts PT - marketscreener.com
Portuguese merger review of Alcon-Staar deal ends - MLex
Wet Age-Related Macular Degeneration Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu - Barchart.com
Alcon, Trinidad Eye Hospital bring free eye care to communities - Trinidad and Tobago Newsday
The Truth About Alcon Inc.: Is This ‘Boring’ Eye Company Your Sleeper Money Move? - AD HOC NEWS
Why STAAR Surgical (STAA) Is Down 5.2% After Shareholders Reject Alcon Deal And Board Power Shifts - Yahoo Finance
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):